As of Nov 21, 2024, the Innoviva stock's PE ratio is 18.87. This takes into account the latest EPS of $1.01 and stock price of $19.06. The PE ratio has increased by 101% from its last 4 quarters average of 9.4.
The PE ratio of Innoviva has averaged 10.47 over the last nine years. The current price-to-earnings ratio of 18.87 is 80% more than the historical average. Analyzing the last nine years, INVA's PE ratio reached its highest point in the Jun 2016 quarter at 61.94, when the price was $10.53 and the EPS was $0.17. The lowest point was recorded in the Sep 2022 quarter, when it reached 2.68 with a price of $11.61 and an EPS of $4.33.
Maximum annual increase: 105.39% in 2019
Maximum annual decrease: -60.79% in 2018
Year | PE ratio | Change |
---|---|---|
2023 | 5.83 | 34.95% |
2022 | 4.32 | -18.8% |
2021 | 5.32 | -5.17% |
2020 | 5.61 | -38.62% |
2019 | 9.14 | 105.39% |
2018 | 4.45 | -60.79% |
2017 | 11.35 | -42.71% |
2016 | 19.81 | N/A |
2015 | N/A | N/A |
2014 | N/A | N/A |
The current PE ratio of INVA is above its 3, 5 and 10-year averages.
Stock name | PE ratio | Market cap |
---|---|---|
INVA Innoviva Inc | 18.87 | $1.19B |
OPTN OptiNose Inc | N/A | $59.58M |
OPK Opko Health Inc | N/A | $1.06B |
ORGO Organogenesis Holdings Inc | N/A | $532.96M |
As of Nov 21, 2024, INVA stock has a price to earnings ratio of 18.87.
The 3-year average PE ratio for INVA stock is 7.51.
The 5-year average PE ratio for INVA stock is 6.84.
Over the last nine years, the quarterly PE ratio reached its highest level at 61.94 in the Jun 2016 quarter.
INVA's price to earnings ratio is currently 80% above its 9-year historical average.
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Nov 21, 2024), Innoviva's share price is $19.06. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $1.01. Therefore, Innoviva's price to earnings ratio for today is 18.87. PE RATIO(18.87) = STOCK PRICE($19.06) / TTM EPS($1.01)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.